{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:10:18Z","timestamp":1778861418002,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["CNPq-Brasil - 400455\/2014-5"],"award-info":[{"award-number":["CNPq-Brasil - 400455\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jgar.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T12:53:23Z","timestamp":1560430403000},"page":"279-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment"],"prefix":"10.1016","volume":"18","author":[{"given":"Lis Marie","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimar","family":"L\u00f6benberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikoletta","family":"Fotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Lima Barros","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Cesar","family":"Cotrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e1dia","family":"Bou-Chacra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jgar.2019.06.006_bib0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.jgar.2019.06.006_bib0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijantimicag.2012.01.003","article-title":"In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa","volume":"39","author":"Costa Lima","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jgar.2019.06.006_bib0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/30.6.827","article-title":"The activity of hydroxynaphthoquinones against Leishmania donovani","volume":"30","author":"Croft","year":"1992","journal-title":"J Antimicrob Chemother"},{"issue":"1\u20132","key":"10.1016\/j.jgar.2019.06.006_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijpharm.2018.06.018","article-title":"Promising nanotherapy in treating leishmaniasis","volume":"547","author":"Souza","year":"2018","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.jgar.2019.06.006_bib0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2217\/fmb.12.85","article-title":"Modes of action of Leishmanicidal antimicrobial peptides","volume":"7","author":"Marr","year":"2012","journal-title":"Future Microbiol"},{"issue":"26","key":"10.1016\/j.jgar.2019.06.006_bib0030","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","article-title":"The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation","volume":"31","author":"Kedmi","year":"2010","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jgar.2019.06.006_bib0035","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.carbpol.2011.01.005","article-title":"Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate\u2013chitosan nanoparticles","volume":"84","author":"Anitha","year":"2011","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.jgar.2019.06.006_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9781603","article-title":"Buparvaquone nanostructured lipid carrier: development of an affordable delivery system for the treatment of Leishmaniases","volume":"2017","author":"Monteiro","year":"2017","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.jgar.2019.06.006_bib0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijantimicag.2017.01.033","article-title":"Targeting Leishmania amazonensis amastigotes through macrophage internalization of a hydroxymethylnitrofurazone nanostructured polymeric system","volume":"50","author":"Monteiro","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"13","key":"10.1016\/j.jgar.2019.06.006_bib0050","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jgar.2019.06.006_bib0055","first-page":"159","article-title":"The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes","volume":"9","author":"Wang","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jgar.2019.06.006_bib0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","article-title":"Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi","volume":"130","author":"Reim\u00e3o","year":"2012","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.jgar.2019.06.006_bib0065","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acs.molpharmaceut.8b00097","article-title":"Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis","volume":"15","author":"Smith","year":"2018","journal-title":"Mol Pharm"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519301493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519301493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:23:00Z","timestamp":1778858580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519301493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":13,"alternative-id":["S2213716519301493"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.06.006","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}